WuXi Biologics
Offering End-to-End Solutions
Capabilities Include:
Antibody and payload conjugation development utilizing multiple technologies including WuXi XDC proprietary technologies (e.g., WuXiDAR4 Drug Antibody Ratio Technology Platform ) is available from our large team of highly trained scientists.